JP2024540052A5 - - Google Patents

Info

Publication number
JP2024540052A5
JP2024540052A5 JP2024525206A JP2024525206A JP2024540052A5 JP 2024540052 A5 JP2024540052 A5 JP 2024540052A5 JP 2024525206 A JP2024525206 A JP 2024525206A JP 2024525206 A JP2024525206 A JP 2024525206A JP 2024540052 A5 JP2024540052 A5 JP 2024540052A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
halo
substituents selected
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525206A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540052A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/080058 external-priority patent/WO2023073090A1/en
Publication of JP2024540052A publication Critical patent/JP2024540052A/ja
Publication of JP2024540052A5 publication Critical patent/JP2024540052A5/ja
Pending legal-status Critical Current

Links

JP2024525206A 2021-10-28 2022-10-27 細菌感染の治療に使用するためのイミダゾピリジンアミド及び関連化合物 Pending JP2024540052A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21205213.8 2021-10-28
EP21205213 2021-10-28
PCT/EP2022/080058 WO2023073090A1 (en) 2021-10-28 2022-10-27 Imidazopyridine amides and related compounds for use in the treatment of bacterial infections

Publications (2)

Publication Number Publication Date
JP2024540052A JP2024540052A (ja) 2024-10-31
JP2024540052A5 true JP2024540052A5 (enExample) 2025-12-26

Family

ID=78414322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525206A Pending JP2024540052A (ja) 2021-10-28 2022-10-27 細菌感染の治療に使用するためのイミダゾピリジンアミド及び関連化合物

Country Status (11)

Country Link
US (1) US20250034171A1 (enExample)
EP (1) EP4423097A1 (enExample)
JP (1) JP2024540052A (enExample)
KR (1) KR20240090864A (enExample)
CN (1) CN118159543A (enExample)
AR (1) AR127483A1 (enExample)
AU (1) AU2022377203A1 (enExample)
CA (1) CA3234515A1 (enExample)
IL (1) IL312366A (enExample)
TW (1) TW202325274A (enExample)
WO (1) WO2023073090A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024089170A1 (en) * 2022-10-27 2024-05-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2024223859A1 (en) * 2023-04-26 2024-10-31 Janssen Pharmaceutica Nv Antibacterial compounds
JP2026525955A (ja) 2023-07-18 2026-08-04 ヤンセン ファーマシューティカ エヌ.ベー. ベダキリン、プレトマニド又はデラマニド、及びシトクロムbc1阻害剤を含む、少なくとも三種の抗生物質の組み合わせ製品、並びにマイコバクテリア感染症の治療におけるそれらの使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1527050T1 (sl) 2002-07-25 2010-08-31 Janssen Pharmaceutica Nv Kinolinski derivati in njihova uporaba kot mikobakterijski inhibitorji
RU2576662C2 (ru) 2010-03-18 2016-03-10 Энститю Пастер Корея Противоинфекционные соединения
US8569283B2 (en) 2011-09-01 2013-10-29 Valentina Molteni Compounds and compositions as c-Kit kinase inhibitors
US9199981B2 (en) 2011-09-01 2015-12-01 Novartis Ag Compounds and compositions as C-kit kinase inhibitors
JP6483610B2 (ja) 2012-07-18 2019-03-13 ユニバーシティ オブ ノートルダム デュ ラック 5,5−ヘテロ芳香族抗感染症化合物
WO2015014993A2 (en) 2013-08-02 2015-02-05 Institut Pasteur Korea Anti-infective compounds
CN105524058B (zh) * 2014-10-21 2018-03-27 广州艾格生物科技有限公司 吡唑并[1,5‑a]吡啶类化合物及其应用
MD3316969T2 (ro) 2015-07-02 2022-07-31 Janssen Sciences Ireland Unlimited Co Compuși antibacterieni
MA45377A (fr) 2016-06-16 2019-04-24 Janssen Sciences Ireland Unlimited Co Composés hétérocycliques en tant qu'agents antibacteriens
EP3472152A1 (en) 2016-06-16 2019-04-24 Janssen Sciences Ireland Unlimited Company Heterocyclic compounds as antibacte rials
CN114423758B (zh) 2019-09-13 2025-05-27 爱尔兰詹森科学公司 抗细菌化合物
CA3211592A1 (en) * 2021-03-17 2022-09-22 Jerome Emile Georges Guillemont Antibacterial compounds
MX2023010941A (es) * 2021-03-17 2023-11-28 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos.

Similar Documents

Publication Publication Date Title
CY1111882T1 (el) Παραγωγα κινολινης και η χρηση τους ως μυκοβακτηριακων αναστολεων
KR930005992A (ko) 루코트리엔 생합성 억제제
JP2019512485A5 (enExample)
JP2022548247A5 (enExample)
EA200900358A1 (ru) Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv
CA2446326A1 (en) 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
JP2019518050A5 (enExample)
RU2008119651A (ru) Производные дикарбоновых кислот и их применение
JP2002529532A5 (enExample)
JP2012236838A5 (enExample)
CA2476065A1 (en) Inhibitors of histone deacetylase
HU901275D0 (en) Process for preparation of 2-/1-pyperazinyl/-4-phenyl-cycloalkanepyridine derivatives and manufacturing of pharmaceutical compositions comprising them as active ingredients
JP2004533464A (ja) ヘテロアリールスルホニル側鎖を有するアントラニル酸アミド、その製造方法、その医薬または診断助剤としての使用、およびこの化合物を含有する医薬製剤
JP2013542980A5 (enExample)
JP2019518046A5 (enExample)
CA2547347A1 (en) Diazaindole-dicarbonyl-piperazinyl antiviral agents
HUP9800781A2 (hu) Propanol-amin-származékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények, valamint ezek alkalmazása
NO881306D0 (no) 4-(4-(4-(4-( (2,4-difluorfenyl)-2-(1h-azolylmetyl)-1,3-dioxolan-4-yl)metoksy)fenyl)-1-piperazinyl)fenyl)triazoloner.
JPH09505303A (ja) Hivプロテアーゼ阻害剤のプロドラッグ
JP2026503618A5 (enExample)
RU2001126547A (ru) Производные дифенила
JPS6048957A (ja) 置換2,2−ジメチル−5−フエノキシペンタン酸ベンズアミド化合物およびその製造方法
JP2005514418A5 (enExample)
RO115873B1 (ro) Derivaţi de acid hidroximic, procedee de obţinere a acestora, intermediari pentru realizarea unuia dintre procedee şi compoziţie farmaceutică
RU2004117548A (ru) Амиды антраниловой кислоты и их применение в фармацевтике